Kips Bay Medical Raises $16.5 Million in IPO
Published: Feb 11, 2011
Rodman & Renshaw, LLC, a subsidiary of Rodman & Renshaw Capital Group, Inc. (Nasdaq: RODM), is acting as sole book-running manager of the offering and Newbridge Securities Corporation, Caris & Company and Chardan Capital Markets, LLC are acting as co-managers. This offering is being made solely by means of a prospectus. Copies of the final prospectus relating to the offering, when available, may be obtained from Rodman & Renshaw, LLC at 1251 Avenue of the Americas, New York, NY 10020, via telephone at (212) 430-1710, via email to email@example.com or by visiting the U.S. Securities and Exchange Commission website at http://www.sec.gov.
A registration statement relating to these securities was declared effective by the Securities and Exchange Commission on February 10, 2011. This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
About Kips Bay Medical, Inc:
Kips Bay Medical, Inc., founded in 2007 and headquartered in Minneapolis, Minnesota, is a development stage medical device company focused on developing, manufacturing and commercializing its eSVS MESH for use in coronary artery bypass grafting surgery. Additional information about Kips Bay Medical, Inc. can be found at www.kipsbaymedical.com.
Kips Bay Medical, Inc.
Manny Villafana, Chairman and Chief Executive Officer
Scott Kellen, Chief Financial Officer
SOURCE Kips Bay Medical, Inc.